ULNRC-06716, Presentation Information for Third Pre-Application Meeting Regarding Use of Framatome Fuel - Affidavit: Difference between revisions

From kanterella
Jump to navigation Jump to search
Newer edit →
VisualWikitext
StriderTol Bot insert
 
StriderTol Bot change
Line 19: Line 19:


=Text=
=Text=
{{#Wiki_filter:Enclosure 4 to ULNRC-06716 Affidavit
{{#Wiki_filter:Enclosure 4 to ULNRC-06716
 
Affidavit A F F I D A V I T
: 1. My name is Morris Byram. I am Product Manager, Lice nsing & Regulatory
 
Affairs for Framatome Inc. (Framatome) and as such I a m authorized to execute this Affidavit.
: 2. I am familiar with the criteria applied by Frama tome to determine whether
 
certain Framatome information is proprietary. I am fa miliar with the policies established by
 
Framatome to ensure the proper application of these cri teria.
: 3. I am familiar with the Framatome information contai ned in the
 
slide presentation entitled Callaway VQP Pre-Submit tal Meeting dated February 28, 2022,
 
and referred to herein as Document. Information con tained in this Document has been
 
classified by Framatome as proprietary in accordance with th e policies established by
 
Framatome for the control and protection of propriet ary and confidential information.
: 4. This Document contains information of a proprieta ry and confidential nature
 
and is of the type customarily held in confidence by Frama tome and not made available to the
 
public. Based on my experience, I am aware that other co mpanies regard information of the
 
kind contained in this Document as proprietary and confid ential.
: 5. This Document has been made available to the U.S. Nuclear Regulatory
 
Commission in confidence with the request that the infor mation contained in this Document be
 
withheld from public disclosure. The request for withho lding of proprietary information is made in
 
accordance with 10 CFR 2.390. The information for wh ich withholding from disclosure is
 
requested qualifies under 10 CFR 2.390(a)(4) Trade secrets and commercial or financial
 
information.
: 6. The following criteria are customarily applied by F ramatome to determine
 
whether information should be classified as proprietary:
 
(a) The information reveals details of Framatomes resea rch and development
 
plans and programs or their results.
 
(b) Use of the information by a competitor would permi t the competitor to
 
significantly reduce its expenditures, in time or resources, to design, produce,
 
or market a similar product or service.
 
(c) The information includes test data or analytical techn iques concerning a
 
process, methodology, or component, the application of wh ich results in a
 
competitive advantage for Framatome.
 
(d) The information reveals certain distinguishing aspects of a process,
 
methodology, or component, the exclusive use of which provi des a
 
competitive advantage for Framatome in product optimizat ion or marketability.
 
(e) The information is vital to a competitive advantage held by Framatome, would
 
be helpful to competitors to Framatome, and would like ly cause substantial
 
harm to the competitive position of Framatome.
 
The information in this Document is considered propriet ary for the reasons set forth in
 
paragraph 6(d) above.
: 7. In accordance with Framatomes policies governing th e protection and control
 
of information, proprietary information contained in this Document has been made available, on
 
a limited basis, to others outside Framatome only as req uired and under suitable agreement
 
providing for nondisclosure and limited use of the info rmation.
: 8. Framatome policy requires that proprietary informa tion be kept in a secured
 
file or area and distributed on a need-to-know basis.
: 9. The foregoing statements are true and correct to t he best of my knowledge,
 
information, and belief.


AFFI DAVIT
: 1.      My name is Morris Byram. I am Product Manager, Licensing & Regulatory Affairs for Framatome Inc. (Framatome) and as such I am authorized to execute this Affidavit.
: 2. I am familiar with the criteria applied by Framatome to determine whether certain Framatome information is proprietary. I am familiar with the policies established by Framatome to ensure the proper application of these criteria.
: 3. I am familiar with the Framatome information contained in the slide presentation entitled Callaway VQP Pre-Submittal Meeting dated February 28, 2022, and referred to herein as Document. Information contained in this Document has been classified by Framatome as proprietary in accordance with the policies established by Framatome for the control and protection of proprietary and confidential information.
: 4. This Document contains information of a proprietary and confidential nature and is of the type customarily held in confidence by Framatome and not made available to the public. Based on my experience, I am aware that other companies regard information of the kind contained in this Document as proprietary and confidential.
: 5. This Document has been made available to the U.S. Nuclear Regulatory Commission in confidence with the request that the information contained in this Document be withheld from public disclosure. The request for withholding of proprietary information is made in accordance with 10 CFR 2.390. The information for which withholding from disclosure is requested qualifies under 10 CFR 2.390(a)(4) Trade secrets and commercial or financial information.
: 6.      The following criteria are customarily applied by Framatome to determine whether information should be classified as proprietary:
(a)    The information reveals details of Framatomes research and development plans and programs or their results.
(b)    Use of the information by a competitor would permit the competitor to significantly reduce its expenditures, in time or resources, to design, produce, or market a similar product or service.
(c)    The information includes test data or analytical techniques concerning a process, methodology, or component, the application of which results in a competitive advantage for Framatome.
(d)    The information reveals certain distinguishing aspects of a process, methodology, or component, the exclusive use of which provides a competitive advantage for Framatome in product optimization or marketability.
(e)    The information is vital to a competitive advantage held by Framatome, would be helpful to competitors to Framatome, and would likely cause substantial harm to the competitive position of Framatome.
The information in this Document is considered proprietary for the reasons set forth in paragraph 6(d) above.
: 7.      In accordance with Framatomes policies governing the protection and control of information, proprietary information contained in this Document has been made available, on a limited basis, to others outside Framatome only as required and under suitable agreement providing for nondisclosure and limited use of the information.
: 8.      Framatome policy requires that proprietary information be kept in a secured file or area and distributed on a need-to-know basis.
: 9. The foregoing statements are true and correct to the best of my knowledge, information, and belief.
I declare under penalty of perjury that the foregoing is true and correct.
I declare under penalty of perjury that the foregoing is true and correct.
Executed on: (2/11/2022)
Executed on: (2/11/2022)
BYRAM        Morris      Digitally signed by BYRAM Morris Date: 2022.02.11 08:21:55 -08'00' (NAME) morris.byram@framatome.com}}
 
Digitally signed by BYRAM Morris
____________________________________ BYRAM MorrisDate: 2022.02.11 08:21:55 -08'00' (NAME)
 
morris.byram@framatome.com}}

Revision as of 18:02, 18 November 2024

Presentation Information for Third Pre-Application Meeting Regarding Use of Framatome Fuel - Affidavit
ML22047A097
Person / Time
Site: Callaway 
Issue date: 02/11/2022
From: Morris B
Framatome
To:
Office of Nuclear Reactor Regulation
Shared Package
ML22047A092 List:
References
ULNRC-06716
Download: ML22047A097 (4)
v • d • e


Text

Enclosure 4 to ULNRC-06716

Affidavit A F F I D A V I T

1. My name is Morris Byram. I am Product Manager, Lice nsing & Regulatory

Affairs for Framatome Inc. (Framatome) and as such I a m authorized to execute this Affidavit.

2. I am familiar with the criteria applied by Frama tome to determine whether

certain Framatome information is proprietary. I am fa miliar with the policies established by

Framatome to ensure the proper application of these cri teria.

3. I am familiar with the Framatome information contai ned in the

slide presentation entitled Callaway VQP Pre-Submit tal Meeting dated February 28, 2022,

and referred to herein as Document. Information con tained in this Document has been

classified by Framatome as proprietary in accordance with th e policies established by

Framatome for the control and protection of propriet ary and confidential information.

4. This Document contains information of a proprieta ry and confidential nature

and is of the type customarily held in confidence by Frama tome and not made available to the

public. Based on my experience, I am aware that other co mpanies regard information of the

kind contained in this Document as proprietary and confid ential.

5. This Document has been made available to the U.S. Nuclear Regulatory

Commission in confidence with the request that the infor mation contained in this Document be

withheld from public disclosure. The request for withho lding of proprietary information is made in

accordance with 10 CFR 2.390. The information for wh ich withholding from disclosure is

requested qualifies under 10 CFR 2.390(a)(4) Trade secrets and commercial or financial

information.

6. The following criteria are customarily applied by F ramatome to determine

whether information should be classified as proprietary:

(a) The information reveals details of Framatomes resea rch and development

plans and programs or their results.

(b) Use of the information by a competitor would permi t the competitor to

significantly reduce its expenditures, in time or resources, to design, produce,

or market a similar product or service.

(c) The information includes test data or analytical techn iques concerning a

process, methodology, or component, the application of wh ich results in a

competitive advantage for Framatome.

(d) The information reveals certain distinguishing aspects of a process,

methodology, or component, the exclusive use of which provi des a

competitive advantage for Framatome in product optimizat ion or marketability.

(e) The information is vital to a competitive advantage held by Framatome, would

be helpful to competitors to Framatome, and would like ly cause substantial

harm to the competitive position of Framatome.

The information in this Document is considered propriet ary for the reasons set forth in

paragraph 6(d) above.

7. In accordance with Framatomes policies governing th e protection and control

of information, proprietary information contained in this Document has been made available, on

a limited basis, to others outside Framatome only as req uired and under suitable agreement

providing for nondisclosure and limited use of the info rmation.

8. Framatome policy requires that proprietary informa tion be kept in a secured

file or area and distributed on a need-to-know basis.

9. The foregoing statements are true and correct to t he best of my knowledge,

information, and belief.

I declare under penalty of perjury that the foregoing is true and correct.

Executed on: (2/11/2022)

Digitally signed by BYRAM Morris

____________________________________ BYRAM MorrisDate: 2022.02.11 08:21:55 -08'00' (NAME)

morris.byram@framatome.com

Retrieved from "https://kanterella.com/w/index.php?title=ULNRC-06716,_Presentation_Information_for_Third_Pre-Application_Meeting_Regarding_Use_of_Framatome_Fuel_-_Affidavit&oldid=3734362"